Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $303.46M. Across the group, the median move over the past trading day is +1.42%. Price change over the past year runs from −33.8% to +308.0% across the middle 80 percent of the group, with a median of +4.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +4.54% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $669.65M | Small cap | −27.91% |
| RAC.AX | Racura Oncology Ltd | $303.46M | Small cap | +72.00% |
| SPL.AX | Starpharma Holdings Limited | $252.95M | Small cap | +465.38% |
| 4889.T | Renascience Inc. | $117.04M | Small cap | −37.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.